Substrate viscosity impairs temozolomide-mediated inhibition of glioblastoma cells' growth.
Biochim Biophys Acta Mol Basis Dis
; 1868(11): 166513, 2022 11 01.
Article
em En
| MEDLINE
| ID: mdl-35932892
ABSTRACT
BACKGROUND:
The mechanical state of the extracellular environment of the brain cells considerably affects their phenotype during the development of central nervous system (CNS) pathologies, and when the cells respond to drugs. The reports on the evaluation of the viscoelastic properties of different brain tumors have shown that both tissue stiffness and viscosity can be altered during cancer development. Although a compelling number of reports established the role of substrate stiffness on the proliferation, motility, and drug sensitivity of brain cancer cells, there is a lack of parallel data in terms of alterations in substrate viscosity.METHODS:
Based on viscoelasticity measurements of rat brain samples using strain rheometry, polyacrylamide (PAA) hydrogels mimicking elastic and viscous parameters of the tissues were prepared. Optical microscopy and flow cytometry were employed to assess the differences in glioblastoma cells morphology, proliferation, and cytotoxicity of anticancer drug temozolomide (TMZ) due to increased substrate viscosity.RESULTS:
Our results indicate that changes in substrate viscosity affect the proliferation of untreated glioma cells to a lesser extent, but have a significant impact on the apoptosis-associated depolarization of mitochondria and level of DNA fragmentation. This suggests that viscosity sensing and stiffness sensing machinery can activate different signaling pathways in glioma cells.CONCLUSION:
Collected data indicate that viscosity should be considered an important parameter in in vitro polymer-based cell culture systems used for drug screening.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Encefálicas
/
Glioblastoma
/
Glioma
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article